The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b study of gemcitabine, nab-paclitaxel, and ficlatuzumab in patients with advanced pancreatic cancer.
 
Kimberly Perez
No Relationships to Disclose
 
Douglas Adam Rubinson
No Relationships to Disclose
 
James M. Cleary
Honoraria - Agios
Research Funding - Merck
Travel, Accommodations, Expenses - Agios; Roche
 
Jeffrey A. Meyerhardt
Honoraria - Chugai Pharma; Ignyta
Consulting or Advisory Role - Genentech/Roche
 
Anuj K. Patel
No Relationships to Disclose
 
Thomas Adam Abrams
Honoraria - Bayer; Bristol-Myers Squibb; Celgene
Consulting or Advisory Role - Aduro Biotech; Bristol-Myers Squibb
Research Funding - Celgene; Lilly
Travel, Accommodations, Expenses - Lilly
 
Osama E. Rahma
Honoraria - Clinical Care Options; Merck; MI Bioresearch
Consulting or Advisory Role - Alcimed; Celgene; Five Prime Therapeutics; Gfk; Merck; Merck; Putnam Associates
Research Funding - Amgen (Inst); Merck
Travel, Accommodations, Expenses - Clinical Care Options; Merck
 
Srivatsan Raghavan
No Relationships to Disclose
 
Andrew Aguirre
No Relationships to Disclose
 
Michael N. Needle
Employment - Aveo/Biodesix
Leadership - Aveo/Biodesix
Stock and Other Ownership Interests - Aveo/Biodesix
 
Koushik Das
No Relationships to Disclose
 
Jason Pitarresi
No Relationships to Disclose
 
Basil Bakir
No Relationships to Disclose
 
Anil K. Rustgi
No Relationships to Disclose
 
Brian M. Wolpin
Honoraria - G1 Therapeutics
Consulting or Advisory Role - Genentech